Taro Pharmaceutical Industries Ltd. Provides Results for Quarter Ended June 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three month period ended June 30, 2013.

•Net sales of $153.2 million, decreased $6.0 million, or 3.7%

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC